LAB-CFS together with baicalein controls the activation of the NF-κB signaling pathway and thus reduces the levels of inflammatory cytokines associated with mastitis. This evidence concerns the gene NFKB1 and myalgic encephalomeyelitis/chronic fatigue syndrome.